Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

SSkye Bioscience, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
S

Skye Bioscience, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions

News

News

  • Skye Bioscience and Redx Pharma Announce Transaction Agreement and $125 Million in Financings
    Aug 14, 2026Skye Bioscience, Inc. (SKYE) News Releases
  • Skye Announces Cohort Review Committee Approved Opening of Cohort 2 Based on Favorable Safety Data from First Four Participants Treated in Cohort 1
    May 20, 2026Skye Bioscience, Inc. (SKYE) News Releases
  • UPDATE – Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update
    May 12, 2026Skye Bioscience, Inc. (SKYE) News Releases
  • Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update
    May 11, 2026Skye Bioscience, Inc. (SKYE) News Releases
  • Skye Bioscience Presenting at GLP-1-Based Therapeutics Summit
    Apr 7, 2026Skye Bioscience, Inc. (SKYE) News Releases
  • Skye Bioscience Treats First Patient in Nimacimab Higher-Dose Expansion Study Evaluating Exposure-Response to Inform Phase 2b Dose Selection for GLP-1 Combination Development
    Apr 2, 2026Skye Bioscience, Inc. (SKYE) News Releases
  • 2025 Year-end & Q4 Financial Results and Update
    Mar 10, 2026Skye Bioscience

    See Skye's 2025 year-end and Q4 webcast, transcript and news release. The post 2025 Year-end & Q4 Financial Results and Update appeared first on Skye Bioscience.

  • Skye Bioscience Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
    Mar 10, 2026Skye Bioscience, Inc. (SKYE) News Releases
  • Skye Bioscience to Announce 2025 Financial Results and Business Update on March 10, 2026
    Mar 5, 2026Skye Bioscience, Inc. (SKYE) News Releases
  • Skye Reports Positive CBeyond Phase 2a Extension Interim Study Results for Nimacimab in Combination With Semaglutide
    Feb 2, 2026Skye Bioscience, Inc. (SKYE) News Releases
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions